To Evaluate Safety and Effectiveness of RovatitanTab.
NCT04398771 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2020-05-21
Summary
To evaluate the safety and effectiveness of a fixed-dose combination containing valsartan and rosuvastatin (Rovatitan® Tablet) in patient with hypertension and hypercholesterolemia
Conditions
- Hypertension
- Hyperlipidemias
Interventions
- DRUG
-
Rosuvastatin/Valsartan
Rovatitan QD for 12 weeks
Sponsors & Collaborators
-
LG Chem
lead INDUSTRY
Principal Investigators
-
Kang seokmin · Severance Hospital
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-01
- Primary Completion
- 2022-01-31
- Completion
- 2022-05-31
More Related Trials
-
Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome
NCT00409578 ·Status: COMPLETED ·Phase: PHASE2
-
Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.
NCT02662894 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension
NCT00353912 ·Status: COMPLETED ·Phase: PHASE3
-
Sacubitril 97 mg and Valsartan 103 mg Film-coated Tablets Relative to Entresto 97 mg/103 mg Film-coated Tablets
NCT06248112 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets
NCT03847506 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg
NCT01918358 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension
NCT00523744 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome
NCT00394745 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension
NCT00350168 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVH
NCT03180593 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia
NCT00254475 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
NCT00386607 ·Status: COMPLETED ·Phase: PHASE3
-
8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension
NCT00327587 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction
NCT00171327 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia
NCT01402843 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension
NCT00591578 ·Status: COMPLETED ·Phase: PHASE3
-
Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects.
NCT00416468 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension
NCT00171054 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Evaluating the Gastrointestinal (GI) Safety and Tolerability of Aliskiren Compared to Ramipril in Essential Hypertension
NCT00631917 ·Status: COMPLETED ·Phase: PHASE4
-
Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent
NCT00589732 ·Status: COMPLETED ·Phase: PHASE4
-
Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects.
NCT00416728 ·Status: COMPLETED ·Phase: PHASE1
-
Effects and Safety of Sacubitril/Valsartan on Refractory Hypertension
NCT05545059 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension
NCT05359068 ·Status: COMPLETED ·Phase: PHASE3
-
Additive Effects of Pravastatin and Valsartan
NCT01004237 ·Status: COMPLETED ·Phase: PHASE4
-
Valsartan and Amlodipine in Blood Pressure Management: Fixed-Dose vs. Free Drug Therapy
NCT06487949 ·Status: COMPLETED ·Phase: PHASE4